# Geoffrey Chaiken

> Geoffrey Chaiken is the co-founder and CEO of BlinkRx (Blink Health), a New York-based digital health company rebuilding how prescription drugs get priced, paid for, and delivered. The son and grandson of physicians, he gave up a career in medicine to attack what he calls the real bottleneck in healthcare - not discovering new cures, but getting existing ones into patients' hands at a fair price. With his younger brother Matthew, he has raised more than half a billion dollars to digitize both the patient front end and the pharmaceutical industry's back end, partnering with drug makers and tens of thousands of pharmacies to strip middlemen out of the medication supply chain.

- **Role:** Co-Founder & CEO at BlinkRx (Blink Health)
- **Organizations:** BlinkRx (Blink Health), Brave Warrior Advisors, Marinus Pharmaceuticals
- **Nationality:** American
- **Education:** BA, Biology and Philosophy, Yale University, MBA, Harvard Business School
- **Known for:** Co-founded and scaled BlinkRx/Blink Health, which has raised more than $500M (reported $576M) from investors including 8VC and Sweetwater Private Equity, Built a digital pharmacy network reaching tens of thousands of retail pharmacies including Walmart, Costco and major grocery chains, Named to Fortune 40 Under 40 (2018)

## Career timeline

- **2000s** — Interned at Rockefeller University in the lab of Nobel laureate neuroscientist Paul Greengard
- **2000s** — Founded Marinus Pharmaceuticals, a specialty pharma company developing treatments for severe epilepsy; licensed its lead product and closed a $30M financing round
- **2010s** — Investor at Brave Warrior Advisors, helping manage roughly $3B with a focus on technology and pharmaceutical supply chains
- **2014** — Co-founded Blink Health with his brother Matthew Chaiken
- **2016** — Launched Blink Health publicly (February 2016), letting patients pre-pay online for lower-priced prescriptions
- **2018** — Named to Fortune's 40 Under 40 alongside brother Matthew
- **2025** — Leads BlinkRx as it deepens partnerships with pharma manufacturers; launches 'Operation Access Now' (August 2025) and a collaboration with Scienture to expand access to Arbli (December 2025)

## Achievements

- Co-founded and scaled BlinkRx/Blink Health, which has raised more than $500M (reported $576M) from investors including 8VC and Sweetwater Private Equity
- Built a digital pharmacy network reaching tens of thousands of retail pharmacies including Walmart, Costco and major grocery chains
- Named to Fortune 40 Under 40 (2018)
- Honored by Sweetwater Private Equity for his leadership of Blink Health
- Earlier founded Marinus Pharmaceuticals and closed a $30M financing round for severe-epilepsy treatments

## Latest updates

- **2025-08** — BlinkRx launched 'Operation Access Now,' a direct-to-consumer drug-access initiative announced amid federal pressure on pharma to lower prices.
- **2025-12** — Scienture and BlinkRx announced a strategic collaboration to expand national access to Arbli, an FDA-approved ready-to-use oral suspension of losartan potassium.

## Links

- Website: https://blinkrx.com
- LinkedIn: http://www.linkedin.com/in/geoffrey-chaiken-7838905
- Twitter/X: https://twitter.com/blinkhealth
- Facebook: https://www.facebook.com/BlinkHealth

---

Profile page: https://yespress.io/geoffrey-chaiken
Published by YesPress — https://yespress.io
Last updated: 2026-06-12